Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SMR vs MRNA✓SelectedUSD · MRNASMR vs MRNA performance historyLatest closeAs of-11.81%11/20
Stock and ETF performance explorer

SMR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+31.2%
MRNA return
+153.9%
Excess return
-122.7%
Maximum drawdown
-93.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-11.8%-2.2%-9.6%-11.5%
7D-27.9%-12.7%-15.2%-26.6%
30D-38.9%-20.7%-18.2%-37.1%
3M-63.0%+46.3%-109.2%-64.8%
6M-67.7%+305.2%-372.9%-76.9%
YTD-76.3%+561.2%-637.5%-85.6%
1Y-82.0%+772.1%-854.1%-90.0%
3Y+31.2%+147.0%-115.7%-21.9%
All+31.2%+153.9%-122.7%-21.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling